277 related articles for article (PubMed ID: 4607711)
1. The choice of treatment for operable carcinoma of the breast.
Haagensen CD
Surgery; 1974 Nov; 76(5):685-714. PubMed ID: 4607711
[No Abstract] [Full Text] [Related]
2. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
Rebegea L; Firescu D; Dumitru M; Anghel R
Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313
[TBL] [Abstract][Full Text] [Related]
3. [On the estimation of the prognosis of breast carcinoma].
Zimmermann G; Boeckl O; Karrer K
Krebsarzt; 1968; 23(4):229-37. PubMed ID: 5725559
[No Abstract] [Full Text] [Related]
4. [Risk factors for lymphedema of the arm after mastectomy for breast cancer].
Kasse AA; Diop M; Dieng M; Deme A; Ndaw D; Fall MG; Diop PS; Betel E; Dembele B; Drabo B; Timbely G; Toure P
Dakar Med; 1999; 44(1):32-5. PubMed ID: 10797983
[TBL] [Abstract][Full Text] [Related]
5. Interim report on trial of treatment for operable breast cancer.
Helman P; Bennett MB; Louw JH; Wilkie W; Madden P; Silber W; Sealy R; Heselson J
S Afr Med J; 1972 Sep; 46(38):1374-5. PubMed ID: 4565003
[No Abstract] [Full Text] [Related]
6. Surgical treatment of local recurrences of breast carcinoma in the skin and subcutaneous tissues.
Nieminen S; Hietanen T; Nordman E
Acta Chir Scand; 1979; 145(7):463-5. PubMed ID: 395801
[TBL] [Abstract][Full Text] [Related]
7. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?
Tausch C; Baege A; Dietrich D; Vergin I; Heuer H; Heusler RH; Rageth C
Eur J Surg Oncol; 2013 Aug; 39(8):880-6. PubMed ID: 23735162
[TBL] [Abstract][Full Text] [Related]
8. [Special indications for mastectomy].
Greiner P; Widow W
Zentralbl Chir; 1974 Mar; 99(13):402-8. PubMed ID: 4601280
[No Abstract] [Full Text] [Related]
9. [Lymphedema of the arm after radical breast cancer surgery; staging-justified therapy and the possibilities of prophylaxis].
Henningsen B; Amberger H; Reinheimer E
Z Lymphol; 1979 Jun; 3(1):9-13. PubMed ID: 539066
[No Abstract] [Full Text] [Related]
10. Conservative axillary surgery in breast cancer patients undergoing mastectomy: long-term results.
Cowher MS; Grobmyer SR; Lyons J; O'Rourke C; Baynes D; Crowe JP
J Am Coll Surg; 2014 Apr; 218(4):819-24. PubMed ID: 24655877
[TBL] [Abstract][Full Text] [Related]
11. Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures.
Sagen A; Kaaresen R; Sandvik L; Thune I; Risberg MA
Arch Phys Med Rehabil; 2014 May; 95(5):875-81. PubMed ID: 24389401
[TBL] [Abstract][Full Text] [Related]
12. [Postmastectomy locoregional recurrence and survival in early stage breast cancer patients with one to three axillary lymph node metastases].
Zhang YJ; Sun GQ; Chen J; Chen J; Huang XB; Lin HX; Hu YH; Liu MZ; Yang MT; Guan XX
Ai Zheng; 2009 Apr; 28(4):395-401. PubMed ID: 19622300
[TBL] [Abstract][Full Text] [Related]
13. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.
Ikeda K; Ogawa Y; Kajino C; Deguchi S; Kurihara S; Tashima T; Goto W; Nishiguchi Y; Tokunaga S; Fukushima H; Inoue T
Eur J Surg Oncol; 2014 Jul; 40(7):818-23. PubMed ID: 24768416
[TBL] [Abstract][Full Text] [Related]
14. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
15. Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases.
Wang X; Zhao Y; Cao X
Breast J; 2010; 16(1):32-7. PubMed ID: 20465598
[TBL] [Abstract][Full Text] [Related]
16. Axillary reverse mapping to prevent lymphedema after breast cancer surgery: defining the limits of the concept.
Khan SA
J Clin Oncol; 2009 Nov; 27(33):5494-6. PubMed ID: 19826108
[No Abstract] [Full Text] [Related]
17. Primary carcinoma of the male breast.
Wolloch Y; Dintsman M
Am J Surg; 1973 May; 125(5):628-32. PubMed ID: 4699207
[No Abstract] [Full Text] [Related]
18. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
[TBL] [Abstract][Full Text] [Related]
19. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
Fodor J
Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
[TBL] [Abstract][Full Text] [Related]
20. Primary carcinoma of the breast without axillary lymph node metastases.
Fracchia AA; Rosen PP; Ashikari R
Surg Gynecol Obstet; 1980 Sep; 151(3):375-8. PubMed ID: 7404307
[No Abstract] [Full Text] [Related]
[Next] [New Search]
